Quentis Therapeutics
New York
About Quentis Therapeutics
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $49.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Dec 2018)
- Website: quentistx.com
- Phone: (646) 440-9249
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/quentis-therapeutics-63052 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.